NOS2 and Sepsis: An anti-inflammatory effect of RG-I could be verified by its capacity to reduce the tissue expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), and a possible subsidiary ability to treat sepsis [32].